These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20675349)

  • 1. Characterizing declines in pediatric antidepressant use after new risk disclosures.
    Busch SH; Frank RG; Martin A; Barry CL
    Med Care Res Rev; 2011 Feb; 68(1):96-111. PubMed ID: 20675349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidepressant Regulatory Warnings, Prescription Patterns, Suicidality and Other Aggressive Behaviors in Major Depressive Disorder and Anxiety Disorders.
    Gupta S; Gersing KR; Erkanli A; Burt T
    Psychiatr Q; 2016 Jun; 87(2):329-42. PubMed ID: 26303613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the 2004 Food and Drug Administration pediatric suicidality warning on antidepressant and psychotherapy treatment for new-onset depression.
    Valluri S; Zito JM; Safer DJ; Zuckerman IH; Mullins CD; Korelitz JJ
    Med Care; 2010 Nov; 48(11):947-54. PubMed ID: 20856141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National trends in prescribing antidepressants before and after an FDA advisory on suicidality risk in youths.
    Chen SY; Toh S
    Psychiatr Serv; 2011 Jul; 62(7):727-33. PubMed ID: 21724784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National antidepressant prescribing in children and adolescents with mental health disorders after an FDA boxed warning.
    Mittal M; Harrison DL; Miller MJ; Brahm NC
    Res Social Adm Pharm; 2014; 10(5):781-90. PubMed ID: 24355381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressants and suicide risk: how did specific information in FDA safety warnings affect treatment patterns?
    Busch SH; Frank RG; Leslie DL; Martin A; Rosenheck RA; Martin EG; Barry CL
    Psychiatr Serv; 2010 Jan; 61(1):11-6. PubMed ID: 20044412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. News coverage of FDA warnings on pediatric antidepressant use and suicidality.
    Barry CL; Busch SH
    Pediatrics; 2010 Jan; 125(1):88-95. PubMed ID: 19969614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressant drug therapy and suicide in severely depressed children and adults: A case-control study.
    Olfson M; Marcus SC; Shaffer D
    Arch Gen Psychiatry; 2006 Aug; 63(8):865-72. PubMed ID: 16894062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidepressant prescription rates and suicide attempt rates from 2004 to 2016 in a nationally representative sample of adolescents in the USA.
    Plöderl M; Hengartner MP
    Epidemiol Psychiatr Sci; 2019 Oct; 28(5):589-591. PubMed ID: 29633680
    [No Abstract]   [Full Text] [Related]  

  • 10. The FDA pediatric advisories and changes in diagnosis and treatment of pediatric depression.
    Pfeffer CR
    Am J Psychiatry; 2007 Jun; 164(6):843-6. PubMed ID: 17541037
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of regulatory safety warnings on the use of antidepressants among children and adolescents in Finland.
    Foulon V; Svala A; Koskinen H; Chen TF; Saastamoinen LK; Bell JS
    J Child Adolesc Psychopharmacol; 2010 Apr; 20(2):145-50. PubMed ID: 20415610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants.
    Posner K; Oquendo MA; Gould M; Stanley B; Davies M
    Am J Psychiatry; 2007 Jul; 164(7):1035-43. PubMed ID: 17606655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicians' decisions to prescribe antidepressant therapy in older patients with depression in a US managed care plan.
    Ivanova JI; Bienfait-Beuzon C; Birnbaum HG; Connolly C; Emani S; Sheehy M
    Drugs Aging; 2011 Jan; 28(1):51-62. PubMed ID: 21174487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of antidepressant warnings on prescribing trends in Ontario, Canada.
    Kurdyak PA; Juurlink DN; Mamdani MM
    Am J Public Health; 2007 Apr; 97(4):750-4. PubMed ID: 17329650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased suicide rates in recent antidepressant clinical trials.
    Khan A; Fahl Mar K; Gokul S; Brown WA
    Psychopharmacology (Berl); 2018 May; 235(5):1455-1462. PubMed ID: 29480436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing provider and racial/ethnic variation in response to the FDA antidepressant box warning.
    Cook BL; Wang Y; Sonik R; Busch S; Carson N; Progovac AM; Zaslavsky AM
    Health Serv Res; 2019 Feb; 54 Suppl 1(Suppl 1):255-262. PubMed ID: 30666633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary care physician's attitudes and practices regarding antidepressant use during pregnancy: a survey of two countries.
    Bilszta JL; Tsuchiya S; Han K; Buist AE; Einarson A
    Arch Womens Ment Health; 2011 Feb; 14(1):71-5. PubMed ID: 21116666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressant drugs and the risk of suicide in children and adolescents.
    Isacsson G; Rich CL
    Paediatr Drugs; 2014 Apr; 16(2):115-22. PubMed ID: 24452997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suicidality as a possible side effect of antidepressant treatment.
    Culpepper L; Davidson JR; Dietrich AJ; Goodman WK; Kroenke K; Schwenk TL
    J Clin Psychiatry; 2004 Jun; 65(6):742-9. PubMed ID: 15291649
    [No Abstract]   [Full Text] [Related]  

  • 20. Antidepressant discontinuation and risk of suicide attempt: a retrospective, nested case-control study.
    Valuck RJ; Orton HD; Libby AM
    J Clin Psychiatry; 2009 Aug; 70(8):1069-77. PubMed ID: 19758520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.